Metformin Inhibits Monocyte-to-Macrophage Differentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in Atherosclerosis
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Monocyte-to-macrophage differentiation is a critical event that accentuates atherosclerosis by promoting an inflammatory environment within the vessel wall. In this study, we investigated the molecular mechanisms responsible for monocyte-to-macrophage differentiation and, subsequently, the effect of metformin in regressing angiotensin II (Ang-II)-mediated atheromatous plaque formation in ApoE−/− mice. AMPK activity was dose and time dependently downregulated during phorbol myristate acetate (PMA)-induced monocyte-to-macrophage differentiation, which was accompanied by an upregulation of proinflammatory cytokine production. Of note, AMPK activators metformin and AICAR significantly attenuated PMA-induced monocyte-to-macrophage differentiation and proinflammatory cytokine production. However, inhibition of AMPK activity alone by compound C was ineffective in promoting monocyte-to-macrophage differentiation in the absence of PMA. On the other hand, inhibition of c-Jun N-terminal kinase activity inhibited PMA-induced inflammation but not differentiation, suggesting that inflammation and differentiation are independent events. In contrast, inhibition of STAT3 activity inhibited both inflammation and monocyte-to-macrophage differentiation. By decreasing STAT3 phosphorylation, metformin and AICAR through increased AMPK activation caused inhibition of monocyte-to-macrophage differentiation. Metformin attenuated Ang-II–induced atheromatous plaque formation and aortic aneurysm in ApoE−/− mice partly by reducing monocyte infiltration. We conclude that the AMPK-STAT3 axis plays a pivotal role in regulating monocyte-to-macrophage differentiation and that by decreasing STAT3 phosphorylation through increased AMPK activity, AMPK activators inhibit monocyte-to-macrophage differentiation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A working model of metformin’s anti-inflammatory properties also suggests that metformin, in an AMPK-dependent inhibition of STAT3, prevents the differentiation of monocytes to macrophages”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Vasamsetti et al. 2015
Citations
Cites
1 retracted
Activation of Protein Phosphatase 2A by Palmitate Inhibits AMP-activated Protein Kinase
Wu, Y., Song, P., Xu, J., Zhang, M., & Zou, M.-H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608310200 · Cited by 274 · cited 1×
“AMPK-mediated signaling events are downregulated by lipopolysaccharides (LPSs), free fatty acids, high-fat diets, and lipid infusion in macrophages and endothelial cells (12,13).”
BackgroundRetractedRole of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“Earlier studies showed that the pleiotropic effects of metformin are partly mediated by the activation of AMPK (7,8).”
BackgroundAMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602 · cited 2×
“AMPK functions as a fuel gauge, sensing the changes in the energy status of the cell and, thus, playing a critical role in regulating systemic energy balance (9,10).”
BackgroundKahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799 · cited 1×
“AMPK functions as a fuel gauge, sensing the changes in the energy status of the cell and, thus, playing a critical role in regulating systemic energy balance (9,10).”
BackgroundMacrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669 · cited 3×
“a diverse repertoire of inflammatory mediators (2).”
BackgroundThe immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182 · cited 3×
“Substantial evidence implicates that macrophages are abundantly present at all stages of atherosclerotic disease process (1).”
InfluentialPPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637 · cited 1×
“AMPK activity in the blood is predominantly located in monocytes and lymphocytes as the 1a isoform (25), and a reduction in AMPK activity is associated with various pathophysiological effects (26).”
Background
Cited by
Items 401–431 of 431
Additional file 6 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Cheng, D., Xu, Q., Wang, Y., Li, G., Sun, W., Ma, D., Zhou, S., Liu, Y., Han, L., & Ni, C. (2021) · Figshare · doi:10.6084/m9.figshare.15179375
Zhang, Y., Li, Y., Dai, X., Lin, H., & Ma, L. (2024) · Figshare · doi:10.6084/m9.figshare.26594945
Zhang, Y., Li, Y., Dai, X., Lin, H., & Ma, L. (2024) · Figshare · doi:10.6084/m9.figshare.26594966
Zhang, Y., Li, Y., Dai, X., Lin, H., & Ma, L. (2024) · Figshare · doi:10.6084/m9.figshare.26594972
Additional file 7 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Cheng, D., Xu, Q., Wang, Y., Li, G., Sun, W., Ma, D., Zhou, S., Liu, Y., Han, L., & Ni, C. (2021) · Figshare · doi:10.6084/m9.figshare.15179378
Additional file 5 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Cheng, D., Xu, Q., Wang, Y., Li, G., Sun, W., Ma, D., Zhou, S., Liu, Y., Han, L., & Ni, C. (2021) · Figshare · doi:10.6084/m9.figshare.15179372
Additional file 1 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Cheng, D., Xu, Q., Wang, Y., Li, G., Sun, W., Ma, D., Zhou, S., Liu, Y., Han, L., & Ni, C. (2021) · Figshare · doi:10.6084/m9.figshare.15179360
Drug Repurposing: Harnessing the Therapeutics from Antidiabetic Molecules
Bhatta, A., Mahale, P., Baral, H., Yuvaraj, D. K., & Kaundal, R. K. (2026) · Springer eBooks · doi:10.1007/978-981-95-4522-3_3
Immunoregulatory effect of metformin in monocytes exposed to SARS-CoV-2 spike protein subunit 1
Maurmann, R. M., Davis, K. L., Mosalmanzadeh, N., Schmitt, B. L., & Pence, D. (2026) · Immunometabolism · doi:10.1097/in9.0000000000000078
“While some recent studies have correlated metformin’s anti-inflammatory properties with inhibition of complex I activity and associated reactive oxygen species (ROS) production independent of AMPK activity [24,26,27] , others have pointed out the central role of this energy sensor [28–31] .”
Gao, B., Zeng, Y., Ye, L., Yuan, X., Yang, D., Lin, S., Zhou, J., Liang, B., Jie, Y., Ding, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.27.708352
On Complications After Aortic Surgery : With A Focus On Aortic Graft and Endograft Infections
Gavali, H. (2026) · Uppsala University Publications (Uppsala University)
齋藤, 晶. (2022) · Institutional Repositories DataBase (IRDB)
Almubarak, M., Al-Kuraishy, H. M., Hussain, N. R., Waheed, H. J., Alruwaili, M., Al-Gareeb, A. I., Albuhadily, A. K., Mustafa, A. M., & Batiha, G. E. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11823-w
Liu, S., Tang, D., Kang, M., Tong, S., Chen, S., Wei, W., Lan, Y., Li, B., Han, B., & Li, Y. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116965
Pan, G., Qi, Z., Wu, X., Chang, L., Zhang, W., Zhang, J., Zhong, H., Liu, Y., Lin, C. K. S., Zhang, S., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118183
Lin, H., Sui, Q., Chen, Z., Zhu, J., Huang, X., Yi, Y., Ren, S., Zhang, X., Shan, G., Bian, Y., et al. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102407
Jaradat, A. Q., & Fararjeh, A. (2026) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2026.00617
Chempon, H., Pulipaka, S., Shaikh, A., Chandra, Y., Ganji, S. K., Thennati, R., & Kotamraju, S. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154568
Self-citationCarafa, A., Sessa, R. L., Amendolara, R., Zampetti, S., Mignogna, C., Sciarra, F., D’Onofrio, L., Risi, R., Venneri, M. A., Cavallari, I., et al. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02778-2
Kim, S. G., Park, S. Y., & Choi, H. C. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7524503
Kattupalli, A. S. K. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s10.216
Metformin trong điều trị đái tháo đường typ2 mắc COVID-19 cách nhìn mới trong đại dịch COVID-19
Đinh, T. H., Trần, T. T. H., & Lê, Đ. T. (2023) · Vietnam Journal of Diabetes and Endocrinology · doi:10.47122/vjde.2022.52.2
Park, S., Kim, W.-J., Park, H.-S., Lim, H.-S., Jung, H.-N., & Jung, J. (2026) · Journal of Applied Oral Science · doi:10.1590/1678-7765-2026-0493
Guo, S., Mao, X., & Liu, J. (2023) · doi:10.3389/fimmu.2023.1253433.s001
Yang, P., Wu, Q., Sun, L., Fang, P., Liu, L., Ji, Y., Park, J.-Y., Qin, X., Yang, X., & Wang, H. (2021) · doi:10.3389/fimmu.2021.809208.s001
Wang, Y., Su, W., Li, Y., Yuan, J., Yao, M., Su, X., & Wang, Y. (2022) · doi:10.3389/fimmu.2022.935545.s004
Metadata
- Authors
- Vasamsetti, S. B., Karnewar, S., Kanugula, A. K., Thatipalli, A. R., Kumar, J. M., & Kotamraju, S.
- Affiliations
- Indian Institute of Chemical Technology (IN)
- Centre for Cellular and Molecular Biology (IN)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-12-31
- Volume
- 64
- Issue
- 6
- Pages
- 2028-2041
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2031565266
- Cited by
- 397
- References
- 32
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 32 · 2023: 42 · 2022: 38 · 2021: 63 · 2020: 45 · 2019: 35 · 2018: 37 · 2017: 25 · 2016: 25 · 2015: 12
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Science and Engineering Research Board (F.NO.SR/SO/HS-110/2008)
- Council for Scientific and Industrial Research (EpiHeD-BSC-0118, SMiLE-CSC-0111)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- metformin, monocyte-to-macrophage differentiation, AMPK, STAT3 phosphorylation, atherosclerosis, angiotensin II, inflammatory cytokines, c-Jun N-terminal kinase, aortic aneurysm, ApoE-deficient mice, AICAR, macrophage polarization, inflammation
- MeSH terms
- Animals, Apolipoproteins E, Cell Differentiation, Macrophages, Male, Metformin, Monocytes, Polymethacrylic Acids, Mice, Knockout, Atherosclerosis, STAT3 Transcription Factor, Mice, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.